阿里拉姆制药涨1.87% 股价突破300美元大关

市场透视10-24

北京时间2024年10月24日22时01分，阿里拉姆制药（ALNY.us）股票出现波动，股价大幅上涨1.87%。截至发稿，该股报300.39美元/股，成交量1.9493万股，换手率0.02%，振幅1.83%。最近的财报数据显示，该股实现营业收入6.60亿美元，净利润-16.89百万美元，每股收益-0.13美元，毛利5.91亿美元，市盈率-534.38倍。机构评级方面，在所有33家参与评级的机构中，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2477637954?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-24 22:01","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2477637954","market":"us","top_or_hot":-1,"title":"阿里拉姆制药涨1.87% 股价突破300美元大关","media":"市场透视","content":"<div>\n<p>北京时间2024年10月24日22时01分，阿里拉姆制药（ALNY.us）股票出现波动，股价大幅上涨1.87%。截至发稿，该股报300.39美元/股，成交量1.9493万股，换手率0.02%，振幅1.83%。最近的财报数据显示，该股实现营业收入6.60亿美元，净利润-16.89百万美元，每股收益-0.13美元，毛利5.91亿美元，市盈率-534.38倍。机构评级方面，在所有33家参与评级的机构中，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102422014298e3e428&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>阿里拉姆制药涨1.87% 股价突破300美元大关</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n阿里拉姆制药涨1.87% 股价突破300美元大关\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-24 22:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102422014298e3e428&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年10月24日22时01分，阿里拉姆制药（ALNY.us）股票出现波动，股价大幅上涨1.87%。截至发稿，该股报300.39美元/股，成交量1.9493万股，换手率0.02%，振幅1.83%。最近的财报数据显示，该股实现营业收入6.60亿美元，净利润-16.89百万美元，每股收益-0.13美元，毛利5.91亿美元，市盈率-534.38倍。机构评级方面，在所有33家参与评级的机构中，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102422014298e3e428&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0251143458.SGD","symbol_name":"Fidelity Emerging Markets A-SGD","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102422014298e3e428&s=b","article_id":"2477637954","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102422014298e3e428&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2477637954","pubTimestamp":1729778502,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年10月24日22时01分，阿里拉姆制药股票出现波动，股价大幅上涨1.87%。截至发稿，该股报300.39美元/股，成交量1.9493万股，换手率0.02%，振幅1.83%。机构评级方面，在所有33家参与评级的机构中，70%的券商给予买入建议，27%的券商给予持有建议，3%的券商给予卖出建议。阿里拉姆制药股票所在的生物技术行业中，整体涨幅为0.63%。阿里拉姆制药公司简介：Alnylam Pharmaceuticals是RNA干扰治疗研究的领导者。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0251143458.SGD":"Fidelity Emerging Markets A-SGD","LU1515016050.SGD":"Blackrock Emerging Markets Equity Income A6 SGD-H","LU1046422090.SGD":"Fidelity Pacific A-SGD","LU0880133367.SGD":"UBS (LUX) EQUITY FUND CHINA OPPORTUNITY USD \"P\" (SGD) ACC","BK4581":"高盛持仓","BK4504":"桥水持仓","LU1880383366.USD":"东方汇理中国股票基金 A2 (C)","LU0052756011.USD":"TEMPLETON GLOBAL BALANCED \"A\" (USD) INC","IE00B0JY6N72.USD":"PINEBRIDGE GLOBAL EMERGING MARKETS FOCUS EQUITY \"A\" (USD) ACC","LU2226246903.HKD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"AT4\" (HKD) ACC","BK4588":"碎股","BK4548":"巴美列捷福持仓","LU1267930227.SGD":"TEMPLETON GLOBAL BALANCED \"AS\" (SGD) ACC A","LU1823568750.SGD":"Fidelity Global Technology A-ACC SGD","BK4220":"综合零售","LU1046421795.USD":"富达环球科技A-ACC","BK4587":"ChatGPT概念","LU0067412154.USD":"UBS (LUX) EQUITY FUND -  CHINA OPPORTUNITY \"P\" (USD) ACC","BK4554":"元宇宙及AR概念","LU1105468828.SGD":"Allianz Total Return Asian Equity AM DIS H2-SGD","LU0348816934.USD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"AT\" (USD)","LU0918141705.HKD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"AM\" (HKD) INC","BK4585":"ETF&股票定投概念","BK4531":"中概回港概念","LU1048596156.SGD":"Blackrock Asian Growth Leaders A2 SGD-H","LU0348814723.USD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"A\" (USD) INC  NC","BK4534":"瑞士信贷持仓","BK4139":"生物科技","LU1688375341.USD":"贝莱德中国灵活股票基金","GNPX":"Genprex, Inc.","BK4533":"AQR资本管理(全球第二大对冲基金)","LU1282648689.USD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"AMG\" (USD) INC","BK4575":"芯片概念","LU1152091168.USD":"UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) \"PM\" INC","LU0797268264.HKD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"AT\" (HKD) ACC","LU1008478684.HKD":"UBS (LUX) EQUITY FUND -  CHINA OPPORTUNITY \"P\" (HKD) ACC","BK4558":"双十一","ALNY":"阿尔尼拉姆制药公司","BK4524":"宅经济概念","BK4527":"明星科技股","BK4538":"云计算","BK4579":"人工智能","CNSP":"CNS Pharmaceuticals, Inc.","LU0651946864.USD":"贝莱德新兴市场股票收益A2","LU0918141887.USD":"安联亚洲实际收益股票基金","BK4526":"热门中概股","LU1051768304.USD":"贝莱德新兴市场股票收益A6","IE00BFMHRM44.USD":"NEUBERGER BERMAN GLOBAL EQUITY MEGATRENDS \"A\" (USD) ACC","BK4503":"景林资产持仓","BK4122":"互联网与直销零售"},"translate_title":"Aliram Pharmaceuticals rose 1.87%, stock price broke through the $300 mark","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALNY":0.9,"CNSP":0.6,"GNPX":0.6},"content_text":"北京时间2024年10月24日22时01分，阿里拉姆制药（ALNY.us）股票出现波动，股价大幅上涨1.87%。截至发稿，该股报300.39美元/股，成交量1.9493万股，换手率0.02%，振幅1.83%。最近的财报数据显示，该股实现营业收入6.60亿美元，净利润-16.89百万美元，每股收益-0.13美元，毛利5.91亿美元，市盈率-534.38倍。机构评级方面，在所有33家参与评级的机构中，70%的券商给予买入建议，27%的券商给予持有建议，3%的券商给予卖出建议。阿里拉姆制药股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Chromocell Therapeutics Corporation、Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)、Monopar Therapeutics Inc.涨幅较大，Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Genprex, Inc.较为活跃，换手率分别为221.71%、137.79%、60.32%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)、Tevogen Bio Holdings Inc C/Wts 14/02/2029 (To Pur Com)、180 Life Sciences Corp C/Wts 07/11/2025(To Pur Com)，振幅分别为62.74%、60.32%、25.62%。阿里拉姆制药公司简介：Alnylam Pharmaceuticals是RNA干扰(RNAi)治疗研究的领导者。RNAi是细胞内一种自然发生的生物通路，用于序列特异性沉默和调控基因表达。Alnylam有5种药物上市:Onpattro和Amvuttra治疗hATTR淀粉样变，Givlaari治疗急性肝卟啉，Oxlumo治疗原发性高草酸尿1型，Leqvio治疗高胆固醇血症。它也有几个不同治疗领域的临床项目:遗传药物;cardio-metabolic疾病;肝脏感染性疾病和中枢神经系统/眼部疾病。来自研究合作伙伴的预付费用提高了Alnylam的现金水平，该公司有望从合作伙伴关系下的药物商业化中看到更多的里程碑和版税。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2477637954"}